Quest Laborato.

{
  "main_header": {
    "sid": 10039259,
    "name": "Quest Laborato.",
    "stock_name": "Quest Laborato.",
    "full_name": "Quest Laboratories Ltd",
    "name_url": "stocks-analysis/quest-laborato",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "99.00",
    "chg": -2.1,
    "chgp": "-2.08%",
    "dir": -1,
    "prev_price": "101.10",
    "mcapval": "166.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "QUESTLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0TNW01017",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": 61200,
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/quest-laborato-10039259-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Quest Laboratories Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-quest-laboratories-ltd-fallingrising-3782430",
        "imagepath": "",
        "date": "2026-01-06 02:29:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>On 05-Jan, Quest Laboratories Ltd experienced a notable decline in its share price, dropping ₹4.5 or 4.13% by 9:19 PM. This movement contrasts with the stock’s recent positive momentum over the past month, where it gained 19.84%, significantly outperforming the Sensex’s modest 0.24% rise. However, the year-to-date performance shows a 5.09% decline against the Sensex’s 0.46% gain, signalling some early-year pressure. Over the last year, the stock has underperformed sharply, delivering a negative return of 24.52%, while the Sensex appreciated by 9.35%. This divergence highlights investor concerns despite the company’s underlying strengths.</p>\n<p><strong>Technical Indicators and Trading Activity</strong></p>\n<p>Technically, the stock rem..."
      },
      {
        "title": "Quest Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/quest-laboratories-ltd-is-rated-sell-3781276",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/QuestLaboratori_mojoScore_3781276.png",
        "date": "2026-01-05 10:15:12",
        "description": "Quest Laboratories Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 01 January 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 05 January 2026, providing investors with the latest view on the company’s position in the market."
      },
      {
        "title": "Quest Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/quest-laboratories-ltd-is-rated-sell-3769062",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/QuestLaboratori_mojoScore_3769062.png",
        "date": "2025-12-25 12:58:29",
        "description": "Quest Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the most up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Quest Laborato. Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/quest-laborato-upgraded-to-sell-rating-by-marketsmojo-amid-mixed-fundamentals-3748234",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/QuestLaborato_mojoScore_3748234.png",
        "date": "2025-12-05 10:10:27",
        "description": "Quest Laborato., a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation metrics. This shift reflects a nuanced reassessment of the company’s fundamentals, valuation, financial trends, and technical outlook, providing investors with fresh insights into its current standing amid challenging market conditions."
      },
      {
        "title": "Quest Laboratories Faces Intense Selling Pressure Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/quest-laboratories-faces-severe-selling-pressure-amid-prolonged-downtrend-3721434",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/QuestLaboratori_only_sellers_3721434.png",
        "date": "2025-11-21 15:50:20",
        "description": "Quest Laboratories Ltd is experiencing significant selling pressure, with the stock registering a decline of 2.19% today and showing no buying interest. This persistent downward momentum reflects distress selling signals as the stock continues to underperform both its sector and the broader market indices."
      },
      {
        "title": "Quest Laboratories Q2 FY26: Margin Pressures Mount Despite Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/quest-laboratories-q2-fy26-margin-pressures-mount-despite-revenue-growth-3708053",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/QuestLaboratori_quaterlyResult_3708053.png",
        "date": "2025-11-15 11:22:22",
        "description": "Quest Laboratories Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹143.00 crores, reported mixed results for Q2 FY26, with net profit of ₹4.02 crores declining 1.95% quarter-on-quarter whilst declining 33.66% year-on-year. The stock has faced significant headwinds, trading at ₹86.00 and down 25.61% over the past year, substantially underperforming the broader pharmaceuticals sector which gained 4.05% during the same period."
      },
      {
        "title": "How has been the historical performance of Quest Laborato.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-quest-laborato-3704338",
        "imagepath": "",
        "date": "2025-11-15 00:34:46",
        "description": "Answer:\nThe historical performance of Quest Laborato shows significant growth in various financial metrics over the past few years.\n\nBreakdown:\nQuest Laborato's net sales have increased from 0.62 Cr in Mar'23 to 103.91 Cr in Mar'25, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 0.62 Cr in Mar'23 to 103.91 Cr in Mar'25. The company's total expenditure, excluding depreciation, also rose from 0.53 Cr in Mar'23 to 87.93 Cr in Mar'25, indicating increased operational costs. Operating profit (PBDIT) grew from 0.09 Cr in Mar'23 to 20.22 Cr in Mar'25, showcasing improved profitability, while profit before tax increased from 0.07 Cr in Mar'23 to 18.68 Cr in Mar'25. Profit after tax also saw a substantial rise from 0.05 Cr in Mar'23 to 13.57 Cr in Mar'25. On the balance sheet, total assets grew from 46.94 Cr in Mar'23 to 121.65 Cr in Mar'25, with total liabilities..."
      },
      {
        "title": "Why is Quest Laborato. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-quest-laborato-fallingrising-3699951",
        "imagepath": "",
        "date": "2025-11-14 00:05:55",
        "description": "As of 13-Nov, Quest Laboratories Ltd is experiencing a price increase, with its current price at 94.70, reflecting a change of 6.05 or 6.82% upward. The stock has shown strong performance today, outperforming its sector by 6.67%. Additionally, it has gained 10.05% over the past week and 7.61% over the past month, although it has underperformed on a year-to-date basis with a decline of 21.77%. The stock is currently trading above its 5-day, 20-day, 50-day, and 100-day moving averages, but below its 200-day moving average. However, there is a notable decline in investor participation, as the delivery volume has fallen by 81.01% compared to the 5-day average, indicating a potential concern for future trading activity. There are no positive or negative factors explicitly mentioned that could further explain the stock's recent movement.\n\nBroader market context shows that while Quest Laboratories Ltd has outperfo..."
      },
      {
        "title": "How has been the historical performance of Quest Laborato.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-quest-laborato-3699845",
        "imagepath": "",
        "date": "2025-11-13 23:52:41",
        "description": "Answer:\nThe historical performance of Quest Laborato shows significant growth in net sales and profitability over the past few years.\n\nBreakdown:\nQuest Laborato's net sales have increased dramatically from 0.62 Cr in Mar'23 to 103.91 Cr in Mar'25, indicating a strong upward trend. Total operating income followed a similar trajectory, rising from 59.48 Cr in Mar'22 to 103.91 Cr in Mar'25. The company's total expenditure, excluding depreciation, also grew, reaching 87.98 Cr in Mar'25 from 53.02 Cr in Mar'22. Operating profit (PBDIT) has shown consistent improvement, climbing from 6.52 Cr in Mar'22 to 20.22 Cr in Mar'25, while profit before tax increased from 5.77 Cr in Mar'22 to 18.68 Cr in Mar'25. Consequently, profit after tax rose from 4.11 Cr in Mar'22 to 13.57 Cr in Mar'25. The company's total assets have expanded significantly, from 34.80 Cr in Mar'22 to 121.65 Cr in Mar'25, while total liabilities also..."
      }
    ],
    "total": 117,
    "sid": "10039259",
    "stock_news_url": "https://www.marketsmojo.com/news/quest-laboratories-10039259"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Quest Laboratories Ltd falling/rising?

2026-01-06 02:29:55

Recent Price Movement and Market Context

On 05-Jan, Quest Laboratories Ltd experienced a notable decline in its share price, dropping ₹4.5 or 4.13% by 9:19 PM. This movement contrasts with the stock’s recent positive momentum over the past month, where it gained 19.84%, significantly outperforming the Sensex’s modest 0.24% rise. However, the year-to-date performance shows a 5.09% decline against the Sensex’s 0.46% gain, signalling some early-year pressure. Over the last year, the stock has underperformed sharply, delivering a negative return of 24.52%, while the Sensex appreciated by 9.35%. This divergence highlights investor concerns despite the company’s underlying strengths.

Technical Indicators and Trading Activity

Technically, the stock rem...

Read full news article

Quest Laboratories Ltd is Rated Sell

2026-01-05 10:15:12

Quest Laboratories Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 01 January 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 05 January 2026, providing investors with the latest view on the company’s position in the market.

Read full news article

Quest Laboratories Ltd is Rated Sell

2025-12-25 12:58:29

Quest Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the most up-to-date perspective on the company’s performance and outlook.

Read full news article

Quest Laborato. Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-12-05 10:10:27

Quest Laborato., a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation metrics. This shift reflects a nuanced reassessment of the company’s fundamentals, valuation, financial trends, and technical outlook, providing investors with fresh insights into its current standing amid challenging market conditions.

Read full news article

Quest Laboratories Faces Intense Selling Pressure Amid Prolonged Downtrend

2025-11-21 15:50:20

Quest Laboratories Ltd is experiencing significant selling pressure, with the stock registering a decline of 2.19% today and showing no buying interest. This persistent downward momentum reflects distress selling signals as the stock continues to underperform both its sector and the broader market indices.

Read full news article

Quest Laboratories Q2 FY26: Margin Pressures Mount Despite Revenue Growth

2025-11-15 11:22:22

Quest Laboratories Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹143.00 crores, reported mixed results for Q2 FY26, with net profit of ₹4.02 crores declining 1.95% quarter-on-quarter whilst declining 33.66% year-on-year. The stock has faced significant headwinds, trading at ₹86.00 and down 25.61% over the past year, substantially underperforming the broader pharmaceuticals sector which gained 4.05% during the same period.

Read full news article

How has been the historical performance of Quest Laborato.?

2025-11-15 00:34:46

Answer: The historical performance of Quest Laborato shows significant growth in various financial metrics over the past few years. Breakdown: Quest Laborato's net sales have increased from 0.62 Cr in Mar'23 to 103.91 Cr in Mar'25, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 0.62 Cr in Mar'23 to 103.91 Cr in Mar'25. The company's total expenditure, excluding depreciation, also rose from 0.53 Cr in Mar'23 to 87.93 Cr in Mar'25, indicating increased operational costs. Operating profit (PBDIT) grew from 0.09 Cr in Mar'23 to 20.22 Cr in Mar'25, showcasing improved profitability, while profit before tax increased from 0.07 Cr in Mar'23 to 18.68 Cr in Mar'25. Profit after tax also saw a substantial rise from 0.05 Cr in Mar'23 to 13.57 Cr in Mar'25. On the balance sheet, total assets grew from 46.94 Cr in Mar'23 to 121.65 Cr in Mar'25, with total liabilities...

Read full news article

Why is Quest Laborato. falling/rising?

2025-11-14 00:05:55

As of 13-Nov, Quest Laboratories Ltd is experiencing a price increase, with its current price at 94.70, reflecting a change of 6.05 or 6.82% upward. The stock has shown strong performance today, outperforming its sector by 6.67%. Additionally, it has gained 10.05% over the past week and 7.61% over the past month, although it has underperformed on a year-to-date basis with a decline of 21.77%. The stock is currently trading above its 5-day, 20-day, 50-day, and 100-day moving averages, but below its 200-day moving average. However, there is a notable decline in investor participation, as the delivery volume has fallen by 81.01% compared to the 5-day average, indicating a potential concern for future trading activity. There are no positive or negative factors explicitly mentioned that could further explain the stock's recent movement. Broader market context shows that while Quest Laboratories Ltd has outperfo...

Read full news article

How has been the historical performance of Quest Laborato.?

2025-11-13 23:52:41

Answer: The historical performance of Quest Laborato shows significant growth in net sales and profitability over the past few years. Breakdown: Quest Laborato's net sales have increased dramatically from 0.62 Cr in Mar'23 to 103.91 Cr in Mar'25, indicating a strong upward trend. Total operating income followed a similar trajectory, rising from 59.48 Cr in Mar'22 to 103.91 Cr in Mar'25. The company's total expenditure, excluding depreciation, also grew, reaching 87.98 Cr in Mar'25 from 53.02 Cr in Mar'22. Operating profit (PBDIT) has shown consistent improvement, climbing from 6.52 Cr in Mar'22 to 20.22 Cr in Mar'25, while profit before tax increased from 5.77 Cr in Mar'22 to 18.68 Cr in Mar'25. Consequently, profit after tax rose from 4.11 Cr in Mar'22 to 13.57 Cr in Mar'25. The company's total assets have expanded significantly, from 34.80 Cr in Mar'22 to 121.65 Cr in Mar'25, while total liabilities also...

Read full news article

View All News